LEGAL CONSTRAINTS ON CIVIL LIABILITY RULES APPLICABLE TO ARTIFICIAL INTELLIGENCE TECHNOLOGIES
Lex localis - Journal of Local Self-Government · 02.01.2026 · 767-778
DOI: 10.52152/6racdm94 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lex localis - Journal of Local Self-Government, online erschienen am 02.01.2026. Verfasst von Dr. Abdelli Ouafa und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The accelerating development of artificial intelligence poses a new and formidable challenge to the existing rules of civil liability, whose fundamental purpose is to compensate injured parties for harm suffered as a result of fault or a breach of legal obligation. As intelligent systems become increasingly integrated across diverse fields, the need has emerged to adapt current legal frameworks so as to encompass the damages arising from the actions of these non-human entities. Against this backdrop, multiple theories of liability attribution have come to the fore: liability arising from contractual relationships; the vicarious liability of the principal for the acts of its agent; the treatment of artificial intelligence as a thing subject to the custodianship regime; and the imputation of liability to either the producer or a designated human proxy.
Zitieren
APA
Ouafa, D. A., & Habiba, P. A. (2026). LEGAL CONSTRAINTS ON CIVIL LIABILITY RULES APPLICABLE TO ARTIFICIAL INTELLIGENCE TECHNOLOGIES. Lex localis - Journal of Local Self-Government, 767-778. https://doi.org/10.52152/6racdm94
Vancouver
Ouafa DA, Habiba PA. LEGAL CONSTRAINTS ON CIVIL LIABILITY RULES APPLICABLE TO ARTIFICIAL INTELLIGENCE TECHNOLOGIES. Lex localis - Journal of Local Self-Government. 2026:767-778. doi:10.52152/6racdm94
BibTeX
@article{Ouafa2026,
author = {Ouafa, Dr. Abdelli and Habiba, Prof. Abdelli},
title = {LEGAL CONSTRAINTS ON CIVIL LIABILITY RULES APPLICABLE TO ARTIFICIAL INTELLIGENCE TECHNOLOGIES},
journal = {Lex localis - Journal of Local Self-Government},
year = {2026},
pages = {767--778},
doi = {10.52152/6racdm94}
}
EUVIMED